EBOS Group Limited (ASX: EBO) - Share Price
Current share price for EBO : $17.980 0.22 (1.21%)+
EBOS Group Limited (EBO), an ASX-listed company, is an Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a marketer and distributor of animal care brands. On 31 March 2025, the Group acquired a 100% equity interest in SVS Veterinary Supplies Ltd and PPD Ltd (SVS Group). Additionally, In December 2025, the Group entered into an agreement to obtain control over ABT Nevada LLC.
EBO General Information +
| ASX Code | EBO |
| Website | N/A |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | 3,721 |
| EBO Share Price | $17.980 |
| Day High | $18.400 |
| Day Low | $17.840 |
| Last Close | $18.200 |
| EBO Share Price Movement | $0.22 ( 1.21% ) |
Prices as at 16:40, 10 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
EBOS Group Limited (EBO) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 42.01¢ | 95.77% | 5 Mar 2026 | 27 Mar 2026 | - | - | - |
| HFResult | 48.59¢ | 95.77% | 4 Sep 2025 | 24 Sep 2025 | - | - | - |
| Result | 45.89¢ | 95.77% | 27 Feb 2025 | 21 Mar 2025 | - | - | - |
See all dividends from EBOS Group Limited (EBO) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
EBOS Group Limited (EBO) price-sensitive announcements
EBO - Impact of elevated fuel costs on FY26 earnings outlook
EBOS Group Limited announced an update on their FY26 earnings outlook, highlighting the im
EBOS Group Limited (EBO)
22 Apr 2026 | 7:30 AM
22 Apr 2026 | 7:30 AM
EBO - S&P DJI Announces March 2026 Quarterly Rebalance
On March 6, 2026, S&P Dow Jones Indices announced the results of the March 2026 quarterly
EBOS Group Limited (EBO)
6 Mar 2026 | 5:05 PM
6 Mar 2026 | 5:05 PM
EBO - Shareholders Letter
The interim report for EBOS Group Limited highlights robust revenue growth of 13.0% to $6.
EBOS Group Limited (EBO)
25 Feb 2026 | 7:33 AM
25 Feb 2026 | 7:33 AM
EBO - Directors Declaration
The document is a Directors’ Declaration from EBOS Group Limited concerning their financia
EBOS Group Limited (EBO)
25 Feb 2026 | 7:32 AM
25 Feb 2026 | 7:32 AM
EBOS Group Limited (EBO) Recent ASX Announcements
EBO Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $275.24 | $141.31 | 13.10% | 26.56 | 98.90 | 2.64% | 100.0% |
| 2025F | $243.39 | $124.95 | -15.80% | 30.04 | 87.50 | 2.33% | 100.0% |
| 2024A | $285.24 | $148.43 | 7.40% | 22.30 | 113.67 | 3.43% | 100.0% |
EBO Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| EBOS Group Limited (EBO) | $3,767M | -0.1796 | -0.1006 | 0.1128 | 14.6881 | 16.3302 | 14.6751 | 5.95% | 4.28% | 4.76% |
| Sigma Healthcare Limited (SIG) | $33,130M | 15.7941 | 0.0893 | 0.1688 | 50.2627 | 46.1415 | 39.4773 | 0.63% | 1.13% | 1.48% |
EBO Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Mark Alan Bloom | Non-Executive Director | 16 Sep 2022 |
| Mr Stuart McLauchlan | Non-Executive Director | 1 Jul 2019 |
| Mr Matthew Peter Muscio | Non-Executive Director | 1 Jan 2025 |
| Dr Tracey Leigh Batten | Non-Executive Director | 1 Jul 2021 |
| Ms Julie Tay | Non-Executive Director | 15 May 2023 |
| Ms Coline McConville | Non-Executive Director | 1 Feb 2025 |
| Ms Elizabeth(Liz) Mary Coutts | Non-Executive Director, Non-Executive Chairman | 7 Nov 2013 |
EBOS Group Limited (EBO) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 27 Mar 2026 | MCLAUCHLAN, Stuart | Issued | Indirect Shares | 134 | $22.090 | $2,960.060 |
| 27 Mar 2026 | TAY, Julie | Issued | Direct Shares | 71 | $11.624 | $825.300 |
| 27 Mar 2026 | MCCONVILLE, Coline | Issued | Direct Shares | 22 | $22.090 | $485.980 |
See all changes in directors' interest & trades for EBOS Group Limited (EBO) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
EBO Management
| Name | Position |
|---|---|
| Grant Viney | CEO Animal Care |
| Kristine James | CEO Medical Technology |
| Brett Barons | CEO Symbion & Healthcare Distribution |
| Alistair Gray | Chief Financial Officer |
| Mithran Naiker | Chief Information Officer |
| Martin Krauskopf | Chief Strategy and Corporate Development Officer |
| David Lewis | EGM |
| Simon Bunde | EGM Strategic Operations, ESG and Innovation |
| Jacinta McCarthy | Executive General Manager Human Resources |
| Janelle Cain | General Counsel |
EBO Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EBOS Group Limited (EBO). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 12,985,750 (6.39%) | FirstCape Group Limited |
| 12,854,170 (6.33%) | Australian Super Pty Ltd |
EBO Calendar of Events
| Date | Event |
|---|---|
| 24 February 2027 | Report (Interim) |
| 26 August 2026 | Report (Annual) |
| 26 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
